1Semana·

Teladoc Health Q1'25 Earnings Highlights

$TDOC (+4,9 %)


🔹 Revenue: $629.4M (Est. $619.3M) 🟢; -2.6% YoY

🔹 Adj EBITDA: $58.1M (Est. $53.3M) 🟢; -8% YoY

🔹 Loss per Share: -$0.53 (Est. -$0.34) 🔴

🔹 Total Visits: 4.44M (Est. 4.96M) 🔴; -3.5% YoY


Q2'25 Guidance

🔹 Revenue: $614M–$633M (Est. $625.5M) 🟡

🔹 Adjusted EBITDA: $56M–$70M (Est. $74M) 🔴

🔹 EPS: -$0.40 to -$0.20


FY25 Guidance

🔹 Revenue: $2.468B–$2.576B (Est. $2.521B) 🟡

🔹 Adjusted EBITDA: $263M–$304M (Prev. $278M–$319M) 🔴

🔹 EPS: -$1.40 to -$0.90 (Prev. -$1.10 to -$0.50) 🔴


Q1 Segment Revenue:

🔹 Integrated Care: $389.5M (Est. $379.7M) 🟢; UP +3.3% YoY

🔹 BetterHelp: $239.9M (Est. $237.5M) 🟢; DOWN -11% YoY

🔹 Total Access Fees: $525.7M (Est. $583.8M) 🔴; DOWN -5.6% YoY

🔹 Integrated Care Adj EBITDA: $50.4M; UP +5.7% YoY

🔹 BetterHelp Adj EBITDA: $7.71M; DOWN -50% YoY

3
2 Comentarios

Dude... I never thought it would be such a good idea to sell at 85 after buying at 200 euros....
Sure, it would have been even better not to have gone in at all, but...
from 236 to 6 euros. My personal highlight. Fortunately, I sold back then.
Únase a la conversación